- Nov. 1: #1; vol. 5M
ALAMEDA, Calif. (AP) _ Exelixis Inc. (EXEL) on Thursday reported third-quarter earnings of $126.6 million.
On a per-share basis, the Alameda, California-based company said it had profit of 41 cents.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 19 cents per share.
The drug developer posted revenue of $225.4 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $166.4 million.
Exelixis shares have fallen 51 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $14.95, a decline of 38 percent in the last 12 months.
No comments:
Post a Comment